DOI QR코드

DOI QR Code

Leu432Val Polymorphism of CYP1B1 is Not Associated with Squamous Cell Carcinoma of Esophagus - a Case-Control Study from Kashmir, India

  • Published : 2015.08.03

Abstract

Background: Individual susceptibility to cancer has been attributed to polymorphisms in xenobiotic metabolizing genes. To evaluate the association of the Leu432Val polymorphism of cytochrome P4501B1 (CYP1B1) with esophageal squamous cell carcinoma (ESCC), we conducted a case control study in Kashmir, India, an area with a relatively high incidence of ESCC. Materials and Methods: We recruited 404 histopathologically confirmed ESCC cases, and an equal number of controls, individually matched for sex, age and district of residence to respective cases. Information was obtained on various dietary, lifestyle and environmental factors in face to face interviews, using a structured questionnaire, from each subject. Genotypes were analysed by polymerase chain reaction, restriction fragment length polymorphism and sequencing of randomly selected samples. Conditional logistic regression models were used to calculate odds ratios (ORs) and 95% confidence intervals (95% CIs). Results: Among the three possible variants, we did not find any Leu432Leu genotype of CYP1B1 in the study population and the genotypic distribution of Val432Val and Leu432Val carriers was nearly equal in both cases (89.6% and 10.4%) and controls (88.9% and 11.1%) respectively. We did not find any risk associated with this polymorphism in the current study (OR = 0.64; 95% CI: 0.55 - 1.64). Conclusions: The study indicates that (Leu432Val) polymorphism of CYP1B1, is not associated with ESCC risk. However, replicative studies with larger sample size are needed to substantiate the findings.

Keywords

References

  1. Ayub SG, Ayub T, Khan SN, et al (2011). Epidemiological distribution and incidence of different cancers in Kashmir valley-2002-2006. Asian Pac J Cancer Prev, 12, 1867-72.
  2. Bartsch H, Nair U, Risch A, et al (2000). Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomark Prev, 9, 3-28.
  3. Berber U, Yilmaz I, Yilmaz O, et al (2013). CYP1A1 (Ile462Val), CYP1B1 (Ala119Ser and Val432Leu), GSTM1 (null), and GSTT1 (null) polymorphisms and bladder cancer risk in a Turkish population. Asian Pac J Cancer Prev, 14, 3925-9. https://doi.org/10.7314/APJCP.2013.14.6.3925
  4. Boffetta P (2010). Biomarkers in cancer epidemiology: an integrative approach. Carcinogenesis, 31, 121-6. https://doi.org/10.1093/carcin/bgp269
  5. Buters JT, Sakai S, Richter T, et al (1999). Cytochrome P450 CYP1B1 determines susceptibility to 7, 12-dimethylbenz[a] anthracene-induced lymphomas. Proc Natl Acad Sci U S A, 96, 1977-82. https://doi.org/10.1073/pnas.96.5.1977
  6. Bye H, Prescott NJ, Matejcic M, et al (2011). Populationspecific genetic associations with oesophageal squamous cell carcinoma in South Africa. Carcinogenesis, 32, 1855-61. https://doi.org/10.1093/carcin/bgr211
  7. Chang I, Fukuhara S, Wong DK, et al (2014). Cytochrome P450 1B1 polymorphisms and risk of renal cell carcinoma in men. Tumour Biol, 35, 10223-30. https://doi.org/10.1007/s13277-014-2292-3
  8. Dar NA, Bhat GA, Shah IA, et al (2012). Hookah smoking, nass chewing, and oesophageal squamous cell carcinoma in Kashmir, India. Br J Cancer, 107, 1618-23. https://doi.org/10.1038/bjc.2012.449
  9. Dar NA, Bhat GA, Shah IA, et al (2015). Salt tea consumption and esophageal cancer: A possible role of alkaline beverages in esophageal carcinogenesis. Int J Cancer, 136, 704-10. https://doi.org/10.1002/ijc.29204
  10. Dar NA, Shah IA, Bhat GA, et al (2013). Socioeconomic status and esophageal squamous cell carcinoma risk in Kashmir, India. Cancer Sci, 104, 1231-6. https://doi.org/10.1111/cas.12210
  11. Eslick GD (2009). Epidemiology of esophageal cancer. Gastroenterol Clin North Am, 38, 17-25. https://doi.org/10.1016/j.gtc.2009.01.008
  12. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917. https://doi.org/10.1002/ijc.25516
  13. Gajjar K, Martin-Hirsch PL, Martin FL (2012). CYP1B1 and hormone-induced cancer. Cancer letters, 324, 13-30. https://doi.org/10.1016/j.canlet.2012.04.021
  14. Garte S (1998). The role of ethnicity in cancer susceptibility gene polymorphisms: the example of CYP1A1. Carcinogenesis, 19, 1329-32. https://doi.org/10.1093/carcin/19.8.1329
  15. Go R-E, Hwang K-A, Choi K-C (2015). Cytochrome P450 1 family and cancers. J Steroid Biochem Molecular Biol, 147, 24-30. https://doi.org/10.1016/j.jsbmb.2014.11.003
  16. Guengerich FP (2008). Cytochrome p450 and chemical toxicology. Chem Res Toxicol, 21, 70-83. https://doi.org/10.1021/tx700079z
  17. Hakami R, Mohtadinia J, Etemadi A, et al (2008). Dietary intake of benzo(a)pyrene and risk of esophageal cancer in north of Iran. Nutr Cancer, 60, 216-21. https://doi.org/10.1080/01635580701684831
  18. Hamrah MS, Hamrah MH, Rabi M, et al (2014). Prevalence of esophageal cancer in the northern part of afghanistan. Asian Pac J Cancer Prev, 15, 10981.
  19. Hanna IH, Dawling S, Roodi N, et al (2000). Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res, 60, 3440-4.
  20. He XF, Wei J, Liu ZZ, et al (2014). Association between CYP1A2 and CYP1B1 polymorphisms and colorectal cancer risk: a meta-analysis. PloS one, 9, 100487. https://doi.org/10.1371/journal.pone.0100487
  21. Hrycay EG, Bandiera SM (2015). Monooxygenase, peroxidase and peroxygenase properties and reaction mechanisms of cytochrome P450 enzymes. in 'monooxygenase, peroxidase and peroxygenase properties and mechanisms of cytochrome P450', Eds Springer, 1-61
  22. Islami F, Kamangar F, Aghcheli K, et al (2004). Epidemiologic features of upper gastrointestinal tract cancers in Northeastern Iran. Br J Cancer, 90, 1402-6. https://doi.org/10.1038/sj.bjc.6601737
  23. Islami F, Kamangar F, Nasrollahzadeh D, et al (2009). Socioeconomic status and oesophageal cancer: results from a population-based case-control study in a high-risk area. Int J Epidemiol, 38, 978-88. https://doi.org/10.1093/ije/dyp195
  24. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
  25. Kamangar F, Dores GM, Anderson WF (2006). Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol, 24, 2137-50. https://doi.org/10.1200/JCO.2005.05.2308
  26. Kamangar F, Strickland PT, Pourshams A, et al (2005). High exposure to polycyclic aromatic hydrocarbons may contribute to high risk of esophageal cancer in northeastern Iran. Anticancer Res, 25, 425-8.
  27. Khuroo MS, Zargar SA, Mahajan R, et al (1992). High incidence of oesophageal and gastric cancer in Kashmir in a population with special personal and dietary habits. Gut, 33, 11-5. https://doi.org/10.1136/gut.33.1.11
  28. Kotnis A, Kannan S, Sarin R, et al (2008). Case-control study and meta-analysis of SULT1A1 Arg213His polymorphism for gene, ethnicity and environment interaction for cancer risk. Br J Cancer, 99, 1340-7. https://doi.org/10.1038/sj.bjc.6604683
  29. Li XY, Su M, Huang HH, et al (2007). mtDNA evidence: genetic background associated with related populations at high risk for esophageal cancer between chaoshan and taihang mountain areas in China. Genomics, 90, 474-81. https://doi.org/10.1016/j.ygeno.2007.06.006
  30. Liu F, Luo LM, Wei YG, et al (2015). Polymorphisms of the CYP1B1 gene and hepatocellular carcinoma risk in a Chinese population. Gene, 564, 14-20. https://doi.org/10.1016/j.gene.2015.03.035
  31. Liu JY, Yang Y, Liu ZZ, et al (2014). Association between the CYP1B1 polymorphisms and risk of cancer: a meta-analysis. Mol Genet Genomics, 290, 739-65.
  32. Lopes BA, Emerenciano M, Goncalves BA, et al (2015). Polymorphisms in CYP1B1, CYP3A5, GSTT1, and SULT1A1 Are Associated with Early Age Acute Leukemia. PloS one, 10, 127308.
  33. Louwman WJ, Aarts MJ, Houterman S, et al (2010). A 50% higher prevalence of life-shortening chronic conditions among cancer patients with low socioeconomic status. Br J Cancer, 103, 1742-8. https://doi.org/10.1038/sj.bjc.6605949
  34. Manfred S 2011. Encyclopedia of cancer, New York, Springer Heidelberg Dordrecht New York.
  35. Mir MM, Dar NA (2009). Esophageal cancer in kashmir (India): an enigma for researchers. Int J Health Sci (Qassim), 3, 71-85.
  36. Murray GI, Melvin WT, Greenlee WF, et al (2001). Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1. Ann Rev Pharmacol Toxicol, 41, 297-316. https://doi.org/10.1146/annurev.pharmtox.41.1.297
  37. Murray GI, Taylor MC, McFadyen MC, et al (1997). Tumorspecific expression of cytochrome P450 CYP1B1. Cancer Res, 57, 3026-31.
  38. Rose RL, Hodgson E (2004). Metabolism of toxicants. A textbook of modern toxicol, 111.
  39. Roshandel G, Semnani S, Malekzadeh R, et al (2012). Polycyclic aromatic hydrocarbons and esophageal squamous cell carcinoma. Arch Iran Med, 15, 713-22.
  40. Sambrook J, Rusell 2001. Molecular cloning: a laboratory manual, New York, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
  41. Shi Y, Luo GJ, Zhang L, et al (2012). Interaction between alcohol consumption and CYP 2C19 gene polymorphism in relation to oesophageal squamous cell carcinoma. PloS one, 7, 43412. https://doi.org/10.1371/journal.pone.0043412
  42. Shimada T, Hayes CL, Yamazaki H, et al (1996). Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res, 56, 2979-84.
  43. Shimada T, Watanabe J, Kawajiri K, et al (1999). Catalytic properties of polymorphic human cytochrome P450 1B1 variants. Carcinogene, 20, 1607-13. https://doi.org/10.1093/carcin/20.8.1607
  44. Siddiqi M, Tricker AR, Preussmann R (1988). The occurrence of preformed N-nitroso compounds in food samples from a high risk area of esophageal cancer in Kashmir, India. Cancer letters, 39, 37-43. https://doi.org/10.1016/0304-3835(88)90038-9
  45. Siddiqi MA, Tricker AR, Kumar R, et al (1991). Dietary sources of N-nitrosamines in a high-risk area for oesophageal cancer--Kashmir, India. IARC scientific publications, 210-3.
  46. Sliwinski T, Sitarek P, Stetkiewicz T, et al (2010). Polymorphism of the ER${\alpha}$ and CYP1B1 genes in endometrial cancer in a Polish subpopulation. J Obstet Gynaecol Res, 36, 311-7. https://doi.org/10.1111/j.1447-0756.2009.01143.x
  47. Spink DC, Wu SJ, Spink BC, et al (2008). Induction of CYP1A1 and CYP1B1 by benzo (k) fluoranthene and benzo (a) pyrene in T-47D human breast cancer cells: Roles of PAH interactions and PAH metabolites. Toxicol Applied Pharmacol, 226, 213-24. https://doi.org/10.1016/j.taap.2007.08.024
  48. Su H, Hu N, Shih J, et al (2003). Gene expression analysis of esophageal squamous cell carcinoma reveals consistent molecular profiles related to a family history of upper gastrointestinal cancer. Cancer Res, 63, 3872-6.
  49. Thrift AP, Nagle CM, Fahey PP, et al (2012). The influence of prediagnostic demographic and lifestyle factors on esophageal squamous cell carcinoma survival. Int J Cancer, 131, 759-68. https://doi.org/10.1002/ijc.27420
  50. Wang X-w, Chen Y-l, Luo Y-l, et al (2011). No Association Between the CYP1B1C4326G Polymorphism and Endometrial Cancer Risk: a Meta-analysis. Asian Pac J Cancer Prev, 12, 2343-8.
  51. Wang Z, Tang L, Sun G, et al (2006). Etiological study of esophageal squamous cell carcinoma in an endemic region: a population-based case control study in Huaian, China. BMC Cancer, 6, 287. https://doi.org/10.1186/1471-2407-6-287
  52. Yu PJ, Chen WG, Feng QL, et al (2015). Association between CYP1B1 gene polymorphisms and risk factors and susceptibility to laryngeal cancer. Med Sci Monit, 21, 239-45. https://doi.org/10.12659/MSM.893084
  53. Zhong S, Zhao W, Lu C, et al (2013). Glutathione S-transferase M1 null genotype contributes to increased risk of esophageal carcinoma in Chinese population. Tumour Biol, 34, 2403-7. https://doi.org/10.1007/s13277-013-0790-3
  54. Zhuo XG, Watanabe S (1999). Factor analysis of digestive cancer mortality and food consumption in 65 Chinese counties. J Epidemiol, 9, 275-84. https://doi.org/10.2188/jea.9.275

Cited by

  1. Gene Variant, Alkaline Salt Tea Intake and Risk of Esophageal Squamous Cell Carcinoma vol.70, pp.1, 2018, https://doi.org/10.1080/01635581.2018.1412482
  2. gene in patients with squamous cell carcinoma of the esophagus: an Iranian Mashhad cohort study recruited over 10 years vol.19, pp.6, 2018, https://doi.org/10.2217/pgs-2018-0197
  3. ANXA10 induction by interaction with tumor-associated macrophages promotes the growth of esophageal squamous cell carcinoma pp.13205463, 2019, https://doi.org/10.1111/pin.12771